Loading company…
Tau Therapeutics develops oncology drugs for solid tumors that selectively inhibit the T-type calcium channel.
Based in Charlottesville, US, Tau Therapeutics is a clinical-stage pharmaceutical company developing oncology drugs for solid tumors. Its drugs selectively inhibit the T-type calcium channel. Its stage is recorded as Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in